1. Home
  2. Live Updates
  3. Moleculin biotech inc

Live Breaking News & Updates on Moleculin biotech inc

Stay informed with the latest breaking news from Moleculin biotech inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Moleculin biotech inc and stay connected to the pulse of your community

Moleculin Biotech (NASDAQ:MBRX) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a report released on Sunday morning. The brokerage issued a sell rating on the stock. Other analysts have also recently issued research reports about the company. Maxim Group cut their target price on Moleculin Biotech from $45.00 to $20.00 and set a […]

Roth-mkm , Nasdaq , Moleculin-biotech-inc , Atticus-wealth-management , Exchange-commission , Maxim-group , Moleculin-biotech , Free-report , Wealth-management , Get-free-report , Moleculin-biotech-daily , Nasdaq-mbrx

Moleculin Biotech (MBRX) Announces EMA Grants Orphan Drug Designation for Treatment of Acute Myeloid Leukemia

Moleculin Biotech (MBRX) Announces EMA Grants Orphan Drug Designation for Treatment of Acute Myeloid Leukemia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Walter-klemp , Drug-administration , European-medicines-agency , Nasdaq , Moleculin-biotech-inc , European-union , Trademark-office , Moleculin-biotech , Orphan-drug-designation , Chief-executive-officer , Fast-track-status

Moleculin Biotech Says EMA Grants Orphan Drug Designation To Annamycin To Treat AML

Pharmaceutical company Moleculin Biotech, Inc. (MBRX) announced Thursday that the European Medicines Agency (EMA) has granted Orphan Drug Designation to Annamycin for the treatment of Acute Myeloid Leukemia (AML).

Moleculin-biotech-inc , Drug-administration , European-medicines-agency , Moleculin-biotech , Orphan-drug-designation , Acute-myeloid-leukemia , Fast-track-status ,

European Medicines Agency Grants Orphan Drug Designation to Annamycin in AML

The European Medicines Agency has granted orphan drug designation to annamycin for the treatment of patients with acute myeloid leukemia.

United-states , Walter-klemp , Trademark-office , European-medicines-agency , Moleculin-biotech-inc , Moleculin-biotech , Medicines-agency ,

Philippine Trade Gap Narrows In February

The Philippine foreign trade deficit decreased in February from a year ago as exports grew more rapidly than imports, preliminary data from the Philippine Statistics Authority showed on Thursday.

Oregon , United-states , India , Portland , Oregon-spice-co , Moleculin-biotech-inc , Reliance-industries-ltd , Tesla-inc , Drug-administration , Baron-spices-inc , Oregon-based-spice

Moleculin Announces Presentation of Positive Data Demonstrating High Anti-Cancer Activity of Annamycin and Non-Cardiotoxic Properties

Annamycin demonstrated to be a more potent inhibitor of topoisomerase II-alpha and II-beta while remaining inactive against established cardiomyocyte cultures...

United-states , San-diego , California , University-of-texas , Texas , Houston , American , Jenene-thomas , Walter-klemp , Preliposomal-annamycin-lyophilizate , Facebook , Twitter

Greenidge Generation: Q4 Profit Beats Its Previous Guidance

Greenidge Generation Holdings Inc. (GREE) reported fourth quarter net income from continuing operations of $2.7 million. Earnings per share was $0.36, for the quarter.

Phoenix , Arizona , United-states , Sam-salehpour , Motors-co , Us-federal-aviation-administration , Boeing , Moleculin-biotech-inc , Moleculin-biotech , Aviation-administration , Earnings , Reenidge-generation

Moleculin Biotech Reveals Positive Anti-cancer Data For Annamycin With Non-cardiotoxic Effects

(RTTNews) - Clinical stage pharmaceutical company Moleculin Biotech, Inc. (MBRX) Wednesday revealed positive preclinical data, demonstrating high ...

United-states , San-diego , California , American , Trademark-office , Moleculin-biotech-inc , American-association-for-cancer-research , Moleculin-biotech , American-association , Cancer-research , United-states-patent

Centaur Media Receives Takeover Proposal From Waterland Private; Stock Soars

Advertising agency, Centaur Media Plc. (CAU.L), Wednesday announced that it has received a proposal from Waterland Private Equity Investments B.V. to acquire the company's issued and to be issued shares.

India , Sam-salehpour , Reliance-industries-ltd , Us-federal-aviation-administration , Moleculin-biotech-inc , Tesla-inc , Boeing , Reliance-industries , Moleculin-biotech , Aviation-administration , Centaur-media-takeover , Entaur-media-acquisition

Ginkgo Bioworks Announces Expansion Of Partnership With Novo Nordisk

Ginkgo Bioworks (DNA) announced the expansion of its strategic partnership with Novo Nordisk under a framework agreement that initially is contemplated to run over five years.

India , Sam-salehpour , Moleculin-biotech-inc , Reliance-industries-ltd , Boeing , Us-federal-aviation-administration , Tesla-inc , Reliance-industries , Moleculin-biotech , Aviation-administration , Novo-nordisk , Inkgo-bioworks